Group 1: Patients with advanced lung cancer eligible for or during immunotherapy

2 trials

Sponsors

Universitätsklinikum Heidelberg Thoraxklinik Heidelberg

Conditions

C34C34.9

Unknown Phase

Development, implementation and evaluation of Educational tools and Decision Aids for immune checkpoint-inhibitors in advanced LUng cancer: a mixed-methods Study (DEDALUS) / Part I: Development

Active, not recruitingDRKS00032683

Universitätsklinikum Heidelberg Thoraxklinik HeidelbergC34.9

Start: 2023-10-02Target: 20Updated: 2026-03-30

Development, implementation and evaluation of Educational tools and Decision Aids for immune checkpoint-inhibitors in advanced LUng cancer: a mixed-methods Study (DEDALUS) / Part II: Evaluation

Active, not recruitingDRKS00035861

Universitätsklinikum Heidelberg Thoraxklinik HeidelbergC34

Start: 2025-03-10Target: 69Updated: 2026-03-30